AZD7762 is a Chk1/2 inhibitor that is utilized as an enhancer of chemotherapy-induced apoptosis of cancer cells; however, its effects on neurons have not been widely studied[38] and the target for this compound in neurons needs to be identified. This evidence concerns the gene CHEK1 and cancer.